j3ff1

Cortex Pharmaceuticals, Inc. Announces Appointment of James S. J. Manuso, Ph.D., as President and Chief Executive Officer, Vice Chairman of the Board of Directors

August 19, 2015

Dr. Arnold S. Lippa, Ph.D., to Continue as Executive Chairman of the Board of Directors and Chief Scientific Officer GLEN ROCK, NJ – (Marketwired – Aug 19, 2015) – Cortex Pharmaceuticals, Inc. (OTCQB: CORX) (“Cortex” or the “Company”), a leader in the discovery and development of innovative pharmaceuticals for the treatment of breathing disorders, today…

NYBIO Conference Presentation

May 4, 2015

Cortex Pharmaceuticals, Inc. to Present at NewYorkBIO 25th Anniversary Conference

May 1, 2015

Cortex Pharmaceuticals, Inc. Files December 31, 2014 Annual Report on Form 10-K; Provides Update on Current Status and Activities

April 6, 2015

Cortex Pharmaceuticals, Inc. to Present at 7th Annual Biotech Showcase™ 2015

January 9, 2015

Cortex Pharmaceuticals, Inc. to Present at Rodman & Renshaw 16th Annual Global Investment Conference on Wednesday, September 10, 2014

September 10, 2014

Cortex Pharmaceuticals, Inc. Announces Appointment of Two Directors; Expands Board to Five Members

September 4, 2014

Cortex Pharmaceuticals, Inc. Enters Into New License Agreement With the University of Illinois Granting Cortex Patent Rights to the Use of Cannabinoids for the Treatment of Sleep Related Breathing Disorders

July 1, 2014

Cortex Announces Positive Phase 2 Data for Use of Dronabinol in the Treatment of Obstructive Sleep Apnea GLEN ROCK, N.J., July 1, 2014 (GLOBE NEWSWIRE) — Cortex Pharmaceuticals, Inc. (CORX) (“Cortex” or the “Company”), a biopharmaceutical company currently engaged in the development of drugs for respiratory disorders, announced today that it has entered into a…

Author: j3ff1